• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

The PAN Foundation Joins the Medicare Access for Patients Rx Coalition

News
Article

The Patient Access Network (PAN) Foundation has joined MAPRx (Medicare Access for Patients Rx), a coalition of patient, family caregiver, and health professional organizations committed to safeguarding the well-being of patients with chronic diseases and disabilities who rely on Medicare Part D, Medicare’s prescription drug coverage.

The Patient Access Network (PAN) Foundation has joined MAPRx (Medicare Access for Patients Rx), a coalition of patient, family caregiver, and health professional organizations committed to safeguarding the well-being of patients with chronic diseases and disabilities who rely on Medicare Part D, Medicare’s prescription drug coverage.

With this membership, PAN adds its voice and resources to other respected groups who collectively represent millions of Americans. "We’re pleased to be part of this important coalition. We believe that by aligning with other patient and provider groups, we are stronger together and have a larger voice for underinsured Americans," said Dan Klein, PAN’s president and chief executive officer.

Coalition members include the Alliance for Aging Research, the AIDS Institute, the Arthritis Foundation, Caregiver Action Network, National Health Council, National Council on Aging, and more. These organizations share PAN’s concern about ensuring that the Medicare Part D prescription plan works for millions of Americans and that people have access to essential medications. Addressing high out-of-pocket costs is at the core of the coalition’s mission.

As the PAN Foundation expands its advocacy work to increase access and affordability for patients, the power of that collective voice and like-minded partnerships become ever more important. The MAPRx coalition today works with Congress, CMS, the Medicare Payment Advisory Commission, and all stakeholders to strengthen Part D and improve the program.

Read the full release.

Related Videos
Patrick Vermersch, MD, PhD
Pat Van Burkleo
Video 1 - "Diagnosing and Understanding the Pathogenesis of Bronchiectasis"
Video 4 - "Challenges in Autoantibody Screening for Type 1 Diabetes"
Jeff Stark, MD, vice president, head of medical immunology, UCB
Video 7 - "Prior Authorization and Access to Targeted Treatment for Ph+ ALL Patients"
Video 7 - "Prior Authorization and Access to Targeted Treatment for Ph+ ALL Patients"
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.